A water insoluble peptide-hydrogel that shows unique compartmentalization by not allowing any exchange to and from the hydrogel and can protect enzymes from denaturation.
A charged synthetic peptide-based
noncytotoxic hydrogelator was
employed in encapsulation, storage, and sustainable release of different
kinds of drugs, namely, ciprofloxacin (CP), an antibiotic; 5-fluorouracil
(5-FU), an anticancer drug and proteins like lysozyme and bovine serum
albumin (BSA). Hydrogelation of the peptide and its coassembly with
the drug molecules were studied to obtain mechanistic details. All
of the different cargos were capable of sustained and efficient release
from the delivery platform. The drugs were found to retain their activity
post release, while the proteins showed complete retention of their
secondary structure. While about 80% CP was released at physiological
pH over a period of 3 days, 5-FU was better released (73%) at an acidic
pH (5.5) in comparison to the physiological pH (68%). Lysozyme was
better released (82%) than BSA (43%) owing to the smaller size of
the former and negative charge on the latter. Such biocompatible multicargo-releasing
platforms from simple economically viable biomaterials, capable of
sustained and tissue-specific release of cargo, are extremely promising
in topical delivery of therapeutics.
Supramolecular
assembly of short peptides is a crucial process
and has shown numerous potential applications as biomaterials. In
the present work, the hydrogelation process of short peptides containing
C-terminal “Lys–Cys” (KC) residues have been
studied in detail. The N-terminal capping is found to be essential
for effective gelation. Out of 12 peptides we studied, two of them
could form hydrogels efficiently: Ac-VVKC-NH2 and Ac-FFKC-NH2. In both cases, the monomer-to-dimer formation through disulfide
linkages by Cys residues controls the aggregation process. Interestingly,
the presence of H2O2 facilitated the dimerization
and thereby reduced the gelation time but could not impart much effect
on the mechanical properties of the gels. Detailed rheological study
revealed that both hydrogels are thixotropic in nature. Moreover,
they are responsive to glutathione (GSH) due to the presence of disulfide
linkages. However, the hydrogel of Ac-FFKC-NH2 is found
to be stronger and more effective for biological applications. The
thixotropic nature as well as a model drug release study in response
to varying GSH concentration indicates the possible use of the hydrogel
as an injectable local drug delivery vehicle. The hydrogel of Ac-FFKC-NH2 is noncytotoxic in nature. Three-dimensional cell proliferation
has been found to be more effective than 2D, as it mimics the in vivo
situation more closely if not exactly. In the present study, we have
shown that both differentiated RAW macrophages and undifferentiated
THP-1 monocytes could proliferate significantly within the 3D matrix
of the hydrogel, without depicting any apparent cytotoxicity. Thus,
the hydrogel of Ac-FFKC-NH2 has potential for application
in localized drug administration and as a supporting biomaterial to
study basic phenomena involving cell behavior.
Molecules offering simultaneous detection and killing of cancer cells are advantageous. Hybrid of cancer cell-selective, ROS generator betulinic acid and bis-arylidene oxindole with amino propyl-linker is developed. With intrinsic fluorescence, the molecule exhibited cancer cell-specific residence. Further, it generated ROS, triggered apoptosis, and exhibited potent cytotoxicity in cancer cells selectively. We demonstrate the first example and use of isatins as betulinic acid conjugate for selective detection of cancer and subsequent killing of cancer cells via apoptosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.